June 23, 2025Bristol Myers Squibb NYSE:BMY Set to Revolutionize Cancer Treatment with Breakthrough Drug ~1 min.Bristol Myers Squibb Company, a leading pharmaceutical company, is on the verge of revolutionizing cancer treatment with its groundbreaking new drug....
June 12, 2025BMY: Bristol-Myers Squibb Co. Reports Positive Phase 3 Trial Results For Sotyktu ~1 min.Investors are taking notice of Bristol-Myers Squibb Company, as they have recently announced positive phase 3 trial results for their drug Sotyktu. This news has caused BMY shares to rise by 3....
May 14, 2025QuantWave Successfully Achieves Price Target Forecast for Bristol-Myers Squibb Company with 14.06% Profit ~2 min.QuantWave, an automated forecasting platform, recently celebrated a significant achievement in its analytics with the successful price target forecast for the stock of BRISTOL-MYERS SQUIBB COMPANY....
May 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits QuantWave Price Target with 13.0% Profit Margin ~2 min.On April 11, 2025, QuantWave, an automated forecasting platform, released a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price target forecast of 44.12 $, indicating a 13....
May 8, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target as QuantWave Forecast Achieves 7.55% Profit ~1 min.BRISTOL-MYERS SQUIBB COMPANY has seen its stock reach the predicted price target set by QuantWave's automated forecasting platform....
November 26, 2024AbbVie Inc. Executes Impressive Performance at Citis 2024 Global Healthcare Conference ~1 min.AbbVie Inc., a leading pharmaceutical company, recently showcased its strong growth potential and innovative product portfolio at the Citis 2024 Global Healthcare Conference....
December 17, 2024AbbVie Inc. ABBV to Acquire Nimble Therapeutics, Boosting Immunology Pipeline ~1 min.AbbVie Inc., a renowned pharmaceutical company, has recently announced its plan to acquire Nimble Therapeutics, a leading biotechnology company, in a move to strengthen its already robust immunology pipeline....
December 18, 2024AbbVie Inc. ABBV to Acquire Nimble Therapeutics in a Game-Changing Move ~1 min.AbbVie Inc., a leading biopharmaceutical company, has announced its acquisition of Nimble Therapeutics, a pioneer in the field of immunology....
December 2, 2024AbbVie Inc. ABBV: A Promising Pharmaceutical Stock with Underrated Potential ~2 min.AbbVie Inc. (ABBV), a renowned pharmaceutical company, has been gaining attention as one of the most undervalued pot stocks in the market....
December 15, 2024Bristol Myers Squibb Announces Record-breaking Dividend Increase ~2 min.Bristol Myers Squibb Company (BMY) has made its mark once again by extending its 93-year dividend streak with a 16th consecutive annual increase....
